Gyre Therapeutics reports shareholder meeting results; all proposals approved

GYRE THERAPEUTICS, INC.

Gordon Carmichael, Ph.D., elected as Class I director with 69,249,334 votes for, 297,881 withheld.
Songjiang Ma elected with 69,385,506 votes for, 161,709 withheld; Ping Zhang with 69,320,687 for, 226,528 withheld.
Non-binding advisory vote on executive compensation approved: 69,505,961 for, 39,318 against, 1,936 abstained.
Ratification of Grant Thornton Zhitong as independent auditor for FY2025 approved: 72,175,754 for, 3,738 against, 146,263 abstained.
Total shares entitled to vote: 93,742,602; broker non-votes reported for director elections and compensation vote.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.